Inventor · disambiguated record
Sang-Kyou Lee
Also filed as: LEE SANG KYOU
12 granted patents·8 pending applications·20 citations·filing 2003–2022
87Inventor score
Top patents by PatentIndex Score
20 records- 0187US11091538B2Use of regulatory T cell-specific surface protein LRIG-1GOOD T CELLS INC·Filed 2018·Granted Aug 17, 2021·2 cites·4 claims
- 0276US11932686B2Use of regulatory T cell-specific surface protein LRIG-1GOOD T CELLS INC·Filed 2021·Granted Mar 19, 2024·0 cites·5 claims
- 0376US2022135662A1Novel use of regulatory t cell-specific surface protein lrig-1GOOD T CELLS INC·Filed 2022·Application pending·0 cites
- 0475US11655287B2Use of regulatory T cell-specific surface protein LRIG-1LEE SANG KYOU·Filed 2012·Granted May 23, 2023·1 cites·6 claims
- 0573US8067376B2Pharmaceutical compositions for transdermal deliveryLEE SEUNG KYOU·Filed 2005·Granted Nov 29, 2011·4 cites·5 claims
- 0673US7700109B2Biomolecule transduction motif Mph-1-BTM and the use thereofFORHUMANTECH CO LTD·Filed 2005·Granted Apr 20, 2010·2 cites·22 claims
- 0772US7902154B2Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the sameFORHUMANTECH CO LTD·Filed 2007·Granted Mar 8, 2011·3 cites·26 claims
- 0868US7723299B2Methods for treating rheumatoid arthritis using a CTLA-4 fusion proteinFORHUMANTECH CO LTD·Filed 2006·Granted May 25, 2010·1 cites·11 claims
- 0968US7354737B2Biomolecule transduction motif Sim-2-BTM and the use thereofFORHUMANTECH CO LTD·Filed 2003·Granted Apr 8, 2008·4 cites·6 claims
- 1064US2020048335A1Novel use of regulatory t cell-specific surface protein lrig-1GOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 1160US11414467B2Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereofGOOD T CELLS INC·Filed 2019·Granted Aug 16, 2022·0 cites·5 claims
- 1255US2019315820A1A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the SameGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 1355US2019338001A1Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the SameGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 1452US10544196B2Composition containing SMAD protein for treatment of autoimmune diseases, a fusion protein comprising SMAD protein, an expression vector and a method for preparing the sameLEE SANG KYOU·Filed 2016·Granted Jan 28, 2020·0 cites·9 claims
- 1552US10494411B2Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereofGOOD T CELLS INC·Filed 2016·Granted Dec 3, 2019·0 cites·2 claims
- 1648US7981446B2Pharmaceutical compositions and methods for delivering nucleic acids into cellsFORHUMANTECH CO LTD·Filed 2008·Granted Jul 19, 2011·3 cites·29 claims
- 1744US2022112515A1Method for Producing Virus-Infected Cell Line and Animal ModelUNIV YONSEI IACF·Filed 2019·Application pending·0 cites
- 1841US2008132450A1Pharmaceutical composition for suppression of apoptosis and method for delivering the sameFORHUMANTECH CO LTD·Filed 2007·Application pending·0 cites
- 1939US2010173840A1Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method ThereofLEE SEUNG KYOU·Filed 2007·Application pending·0 cites
- 2038US2005147971A1Biomolecule transduction motif mph-1-btm and the use thereofFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sang-Kyou Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →